This article shares a common deficit with many other reports addressing cost-effectiveness of the medications used to treat schizophrenia. It is clearly true that the newer medications are much more expensive than the older ones, but tardive dyskinesia (TD) rates have plummeted by about 99 percent with the advent of the modern antipsychotic medications. To put it bluntly, TD is a form of brain damage. When these facts are presented to patients, they always prefer to try the modern antipsychotic medications.

Gregory V. Richardson
Anderson, Ind

From the Nature Index

Paid Content